Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Recently Receives $1.5M in NIH Grants

NEW YORK, Dec. 29 (GenomeWeb News) - Illumina has won around $1.5 million through a pair of recent grants from the US National Institutes of Health, according to the NIH.

 

The grants, which the NIH said are effective as of Dec. 26, but that Illumina had not previously disclosed, include:

  • $506,021 for a high-throughput methylation-profiling system;
  • $194,951 for research into allelic expression-monitoring by array-based genotyping;
  • $603,106 to develop a protease substrate array; and
  • $169,877 to develop an allergy peptide array.
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.